Takashi Morizono Selected Research

HLA-DQA1 antigen (HLA DQA1)

11/2010

Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profiling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Morizono Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 01/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Breast Neoplasms (Breast Cancer) 04/2012
1	Prostatic Intraepithelial Neoplasia 01/2011
1	Carcinogenesis 01/2011
1	Drug-Related Side Effects and Adverse Reactions 11/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2010
1	Kidney Neoplasms (Kidney Cancer) 11/2010
1	Neoplasms (Cancer) 11/2010

Drug/Important Bio-Agent (IBA)

1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Tamoxifen FDA LinkGeneric 04/2012
1	Hormones (Hormone)IBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2011
1	Untranslated RNA (Noncoding RNA)IBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	Long Noncoding RNAIBA 01/2011
1	HLA-DQB1 antigen (HLA DQB1)IBA 11/2010
1	InterferonsIBA 11/2010
1	Interleukin-2 (IL2)IBA 11/2010
1	InterleukinsIBA 11/2010
1	HLA-DQA1 antigen (HLA DQA1)IBA 11/2010

Therapy/Procedure

2	Therapeutics 04/2012 - 11/2010
1	Lasers (Laser) 11/2010